Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The ...
Some people with acute myeloid leukaemia (AML) have difficulty tolerating intensive chemotherapy. For them, venetoclax provides a promising alternative treatment. Up to two thirds of patients achieve ...